VEGF/VEGFR Pathway Inhibitors as Anti-Angiogenic Agents: Present and Future
Journal:
Current Cancer Drug Targets
Volume:
11
Page:
624-653
Author(s):
P. S. Sharma, R. Sharma and T. Tyagi
The Human L1 Element: A Potential Biomarker in Cancer Prognosis, Current Status and Future Directions
Journal:
Current Molecular Medicine
Volume:
11
Page:
286-303
Author(s):
O. Piskareva, W. Lackington, D. Lemass, C. Hendrick, P. Doolan and N. Barron
Aptamers: Potential Applications to Pancreatic Cancer Therapy
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
11
Page:
434-441
Author(s):
Kristy L. Rialon and Rebekah R. White
Anti-Angiogenic Agents in Pancreatic Cancer: A Review
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
11
Page:
464-469
Author(s):
Murwarid M. Assifi and Oscar J. Hines
Phosphatidylinositol 3-Kinase Isoforms as Novel Drug Targets
Journal:
Current Drug Targets
Volume:
12
Page:
1056-1081
Author(s):
Karolina Blajecka, Anna Borgstrom and Alexandre Arcaro
Gene Therapy and Targeted Toxins for Glioma
Journal:
Current Gene Therapy
Volume:
11
Page:
155-180
Author(s):
Maria G. Castro, Marianela Candolfi, Kurt M. Kroeger, Gwendalyn D. King, James F. Curtin, Kader Yagiz, Yohei Mineharu, Hikmat Assi, Mia Wibowo, A. K.M. Ghulam Muhammad, David Foulad, Mariana Puntel and Pedro R. Lowenstein
Progress in the Preclinical Discovery and Clinical Development of Class I and Dual Class I/IV Phosphoinositide 3-Kinase (PI3K) Inhibitors
Journal:
Current Medicinal Chemistry
Volume:
18
Page:
2686-2714
Author(s):
S. J. Shuttleworth, F. A. Silva, A. R.L. Cecil, C. D. Tomassi, T. J. Hill, F. I. Raynaud, P. A. Clarke and P. Workman
mTOR Inhibitors: Facing New Challenges Ahead
Journal:
Current Medicinal Chemistry
Volume:
18
Page:
2743-2762
Author(s):
I. Mavrommati and T. Maffucci
Molecular Chaperone Hsp90 as a Target for Oxidant-Based Anticancer Therapies
Journal:
Current Medicinal Chemistry
Volume:
18
Page:
2816-2825
Author(s):
R. Beck, N. Dejeans, C. Glorieux, R. C. Pedrosa, D. Vasquez, J. A. Valderrama, P. B. Calderon and J. Verrax
Overcoming the Drug Resistance Problem with Second-Generation Tyrosine Kinase Inhibitors: From Enzymology to Structural Models
Journal:
Current Medicinal Chemistry
Volume:
18
Page:
2836-2847
Author(s):
E. Crespan, E. Zucca and G. Maga